SI2167523T1 - Sinteza in uporaba anti-reverznih fosforotioatnih analogov kape obveščevalne RNA - Google Patents

Sinteza in uporaba anti-reverznih fosforotioatnih analogov kape obveščevalne RNA

Info

Publication number
SI2167523T1
SI2167523T1 SI200831256T SI200831256T SI2167523T1 SI 2167523 T1 SI2167523 T1 SI 2167523T1 SI 200831256 T SI200831256 T SI 200831256T SI 200831256 T SI200831256 T SI 200831256T SI 2167523 T1 SI2167523 T1 SI 2167523T1
Authority
SI
Slovenia
Prior art keywords
synthesis
messenger rna
rna cap
phosphorothioate analogs
reverse
Prior art date
Application number
SI200831256T
Other languages
English (en)
Inventor
Jacek Jemielity
Ewa M. Grudzien-Nogalska
Joanna Kowalska
Edward Darzynkiewicz
Robert E. Rhoads
Original Assignee
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, Uniwersytet Warszawski filed Critical Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
Publication of SI2167523T1 publication Critical patent/SI2167523T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SI200831256T 2007-06-19 2008-06-19 Sinteza in uporaba anti-reverznih fosforotioatnih analogov kape obveščevalne RNA SI2167523T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94484207P 2007-06-19 2007-06-19
EP08771474.7A EP2167523B1 (en) 2007-06-19 2008-06-19 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
PCT/US2008/067494 WO2008157688A2 (en) 2007-06-19 2008-06-19 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap

Publications (1)

Publication Number Publication Date
SI2167523T1 true SI2167523T1 (sl) 2014-09-30

Family

ID=40156965

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831256T SI2167523T1 (sl) 2007-06-19 2008-06-19 Sinteza in uporaba anti-reverznih fosforotioatnih analogov kape obveščevalne RNA

Country Status (15)

Country Link
US (1) US8153773B2 (sl)
EP (1) EP2167523B1 (sl)
CN (3) CN104072561B (sl)
AU (1) AU2008265683B2 (sl)
CA (1) CA2692906C (sl)
CY (1) CY1115525T1 (sl)
DK (1) DK2167523T3 (sl)
EA (1) EA017740B1 (sl)
ES (1) ES2500515T3 (sl)
HK (1) HK1200461A1 (sl)
HR (1) HRP20140771T1 (sl)
PL (1) PL2167523T3 (sl)
PT (1) PT2167523E (sl)
SI (1) SI2167523T1 (sl)
WO (1) WO2008157688A2 (sl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109071589A (zh) * 2016-01-29 2018-12-21 华沙大学 5′-硫代磷酸酯mRNA 5′-端(帽)类似物、包含所述类似物的mRNA、其获得方法和用途

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2049665A2 (en) * 2006-07-28 2009-04-22 Applera Corporation Dinucleotide mrna cap analogs
WO2009058911A2 (en) * 2007-10-31 2009-05-07 Applied Biosystems Inc. Preparation and isolation of 5' capped mrna
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
CN101671669B (zh) * 2009-08-27 2012-05-02 浙江大学 一种肝癌靶向性基因表达元件ae及其应用
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2821992A1 (en) 2010-10-01 2012-04-05 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
ES2911677T3 (es) 2011-10-03 2022-05-20 Modernatx Inc Nucleósidos, nucleótidos y ácidos nucleicos modificados, y sus usos
DE12858350T1 (de) 2011-12-16 2021-10-07 Modernatx, Inc. Modifizierte mrna zusammensetzungen
JP6490426B2 (ja) 2012-02-29 2019-03-27 サンガモ セラピューティクス， インコーポレイテッド ハンチントン病を治療するための方法および組成物
EP3501550A1 (en) 2012-04-02 2019-06-26 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
JP6491113B2 (ja) 2013-02-25 2019-03-27 サンガモ セラピューティクス， インコーポレイテッド ヌクレアーゼ媒介性遺伝子破壊を増強するための方法および組成物
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052521A1 (en) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
EP3068905A4 (en) 2013-11-11 2017-07-05 Sangamo BioSciences, Inc. Methods and compositions for treating huntington's disease
EP3960856A1 (en) 2013-11-13 2022-03-02 Children's Medical Center Corporation Nuclease-mediated regulation of gene expression
EP3080143B1 (en) 2013-12-09 2019-02-20 Sangamo Therapeutics, Inc. Methods and compositions for treating hemophilia
AU2014375404C1 (en) 2013-12-30 2020-11-19 CureVac Manufacturing GmbH Methods for RNA analysis
EP3540060A1 (en) 2013-12-30 2019-09-18 CureVac AG Methods for rna analysis
ES2796087T3 (es) 2014-02-03 2020-11-25 Sangamo Therapeutics Inc Métodos y composiciones para el tratamiento de beta talasemia
WO2015143046A2 (en) 2014-03-18 2015-09-24 Sangamo Biosciences, Inc. Methods and compositions for regulation of zinc finger protein expression
US9522936B2 (en) 2014-04-24 2016-12-20 Sangamo Biosciences, Inc. Engineered transcription activator like effector (TALE) proteins
US11110154B2 (en) 2014-05-08 2021-09-07 Sangamo Therapeutics, Inc. Methods and compositions for treating Huntington's Disease
WO2015175642A2 (en) 2014-05-13 2015-11-19 Sangamo Biosciences, Inc. Methods and compositions for prevention or treatment of a disease
EP3151846A4 (en) 2014-06-05 2017-12-27 Sangamo BioSciences, Inc. Methods and compositions for nuclease design
WO2015188933A1 (en) 2014-06-10 2015-12-17 Curevac Ag Methods and means for enhancing rna production
WO2016014837A1 (en) 2014-07-25 2016-01-28 Sangamo Biosciences, Inc. Gene editing for hiv gene therapy
WO2016019144A2 (en) 2014-07-30 2016-02-04 Sangamo Biosciences, Inc. Gene correction of scid-related genes in hematopoietic stem and progenitor cells
US10889834B2 (en) 2014-12-15 2021-01-12 Sangamo Therapeutics, Inc. Methods and compositions for enhancing targeted transgene integration
WO2016154596A1 (en) 2015-03-25 2016-09-29 Editas Medicine, Inc. Crispr/cas-related methods, compositions and components
US20180094243A1 (en) 2015-04-03 2018-04-05 Dana-Farber Cancer Institute, Inc. Composition and methods of genome editing of b-cells
BR112017018368B1 (pt) 2015-04-22 2022-08-02 Curevac Ag Composição contendo rna para uso no tratamento ou profilaxia de doenças tumorais e/ou cancerosas, e uso de um rna para a preparação da composição
CA2986310A1 (en) 2015-05-11 2016-11-17 Editas Medicine, Inc. Optimized crispr/cas9 systems and methods for gene editing in stem cells
AU2016262521A1 (en) 2015-05-11 2017-12-14 Editas Medicine, Inc. CRISPR/CAS-related methods and compositions for treating HIV infection and AIDS
KR20170141217A (ko) 2015-05-12 2017-12-22 상가모 테라퓨틱스, 인코포레이티드 유전자 발현의 뉴클레아제-매개된 조절
EP4108769B1 (en) 2015-05-29 2023-08-30 CureVac Manufacturing GmbH A method for producing and purifying rna, comprising at least one step of tangential flow filtration
AU2016276702B2 (en) 2015-06-09 2022-07-28 Editas Medicine, Inc. CRISPR/CAS-related methods and compositions for improving transplantation
US9957501B2 (en) 2015-06-18 2018-05-01 Sangamo Therapeutics, Inc. Nuclease-mediated regulation of gene expression
EP3317424B1 (en) 2015-07-01 2023-09-06 CureVac Manufacturing GmbH Method for analysis of an rna molecule
HUE055458T2 (hu) 2015-09-21 2021-11-29 Trilink Biotechnologies Llc Kompozíciók és módszerek 5'-Cap RNS-ek szintézisére
EA037993B1 (ru) 2015-09-23 2021-06-21 Сангамо Терапьютикс, Инк. Репрессоры htt и их применение
US11866754B2 (en) 2015-10-16 2024-01-09 Modernatx, Inc. Trinucleotide mRNA cap analogs
WO2017066781A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Mrna cap analogs with modified phosphate linkage
CA3001351A1 (en) 2015-10-21 2017-04-27 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating hepatitis b virus
CN109312338B (zh) 2015-10-30 2022-09-27 爱迪塔斯医药公司 治疗单纯疱疹病毒的crispr/cas相关方法及组合物
US10639383B2 (en) 2015-11-23 2020-05-05 Sangamo Therapeutics, Inc. Methods and compositions for engineering immunity
SG10202005640UA (en) 2015-12-18 2020-07-29 Sangamo Therapeutics Inc Targeted disruption of the mhc cell receptor
US11352631B2 (en) 2015-12-18 2022-06-07 Sangamo Therapeutics, Inc. Targeted disruption of the T cell receptor
EP3394280A1 (en) 2015-12-23 2018-10-31 CureVac AG Method of rna in vitro transcription using a buffer containing a dicarboxylic acid or tricarboxylic acid or a salt thereof
US20190049414A1 (en) 2016-02-15 2019-02-14 Curevac Ag Method for analyzing by-products of rna in vitro transcription
WO2017149139A1 (en) 2016-03-03 2017-09-08 Curevac Ag Rna analysis by total hydrolysis
WO2017162265A1 (en) 2016-03-21 2017-09-28 Biontech Rna Pharmaceuticals Gmbh Trans-replicating rna
WO2017162266A1 (en) 2016-03-21 2017-09-28 Biontech Rna Pharmaceuticals Gmbh Rna replicon for versatile and efficient gene expression
ES2900272T3 (es) 2016-04-22 2022-03-16 BioNTech SE Métodos para proporcionar ARN monocatenario
WO2017191258A1 (en) 2016-05-04 2017-11-09 Curevac Ag Influenza mrna vaccines
US11141474B2 (en) 2016-05-04 2021-10-12 Curevac Ag Artificial nucleic acid molecules encoding a norovirus antigen and uses thereof
US20180126003A1 (en) * 2016-05-04 2018-05-10 Curevac Ag New targets for rna therapeutics
CN116850305A (zh) 2016-05-06 2023-10-10 朱诺治疗学股份有限公司 基因工程化细胞及其制备方法
EP3484870B1 (en) 2016-07-13 2022-11-16 Vertex Pharmaceuticals Incorporated Methods, compositions and kits for increasing genome editing efficiency
EP3500295A2 (en) 2016-08-19 2019-06-26 CureVac AG Rna for cancer therapy
CN110325635B (zh) 2016-08-24 2023-12-26 桑格摩生物治疗股份有限公司 使用工程化的核酸酶调控基因表达
SG10202007392SA (en) 2016-08-24 2020-09-29 Sangamo Therapeutics Inc Engineered target specific nucleases
BR112019007210A2 (pt) 2016-10-20 2019-08-13 Sangamo Therapeutics Inc métodos e composições para o tratamento da doença de fabry
CN110352071A (zh) 2016-10-26 2019-10-18 库瑞瓦格股份公司 脂质纳米颗粒mRNA疫苗
AU2017347928A1 (en) 2016-10-31 2019-05-09 Sangamo Therapeutics, Inc. Gene correction of scid-related genes in hematopoietic stem and progenitor cells
IL266862B2 (en) 2016-12-01 2024-01-01 Sangamo Therapeutics Inc Tau modulators and methods and preparations for their administration
WO2018115527A2 (en) 2016-12-23 2018-06-28 Curevac Ag Mers coronavirus vaccine
EP3558355A2 (en) 2016-12-23 2019-10-30 CureVac AG Henipavirus vaccine
CN110662838B (zh) 2017-02-22 2024-05-28 克里斯珀医疗股份公司 用于基因编辑的组合物和方法
WO2018200943A1 (en) 2017-04-28 2018-11-01 Acuitas Therapeutics, Inc. Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
CA3059793A1 (en) 2017-05-03 2018-11-08 Sangamo Therapeutics, Inc. Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (cftr) gene
US11512287B2 (en) 2017-06-16 2022-11-29 Sangamo Therapeutics, Inc. Targeted disruption of T cell and/or HLA receptors
KR20200024905A (ko) 2017-07-04 2020-03-09 큐어백 아게 신규 핵산 분자
EP3673069A1 (en) 2017-08-22 2020-07-01 CureVac AG Bunyavirales vaccine
US20200283497A1 (en) 2017-09-13 2020-09-10 Biontech Cell & Gene Therapies Gmbh Rna replicon for expressing at cell receptor or an artificial t cell receptor
CA3075549A1 (en) 2017-09-13 2019-03-21 Biontech Rna Pharmaceuticals Gmbh Rna replicon for reprogramming somatic cells
WO2019053003A1 (en) 2017-09-13 2019-03-21 Biontech Rna Pharmaceuticals Gmbh METHODS FOR ENHANCING RNA EXPRESSION IN CELL
RU2020117848A (ru) 2017-11-08 2021-12-08 Куревак Аг Адаптиция последовательности phk
AU2018364660B2 (en) 2017-11-09 2022-05-19 Sangamo Therapeutics, Inc. Genetic modification of cytokine inducible SH2-containing protein (CISH) gene
EP3723796A1 (en) 2017-12-13 2020-10-21 CureVac AG Flavivirus vaccine
WO2019122371A1 (en) 2017-12-21 2019-06-27 Curevac Ag Linear double stranded dna coupled to a single support or a tag and methods for producing said linear double stranded dna
EP3740480B1 (en) 2018-01-17 2024-03-06 Vertex Pharmaceuticals Incorporated Dna-pk inhibitors
AU2019209292B2 (en) 2018-01-17 2023-10-05 Vertex Pharmaceuticals Incorporated Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
WO2019143675A1 (en) 2018-01-17 2019-07-25 Vertex Pharmaceuticals Incorporated Dna-pk inhibitors
AU2019235424B2 (en) * 2018-03-15 2023-12-21 BioNTech SE 5'-cap-trinucleotide- or higher oligonucleotide compounds and their uses in stabilizing RNA, expressing proteins and in therapy
EP3773702A2 (en) 2018-04-05 2021-02-17 CureVac AG Novel yellow fever nucleic acid molecules for vaccination
EP4227319A1 (en) 2018-04-17 2023-08-16 CureVac SE Novel rsv rna molecules and compositions for vaccination
US11690921B2 (en) 2018-05-18 2023-07-04 Sangamo Therapeutics, Inc. Delivery of target specific nucleases
EP3813874A1 (en) 2018-06-27 2021-05-05 CureVac AG Novel lassa virus rna molecules and compositions for vaccination
CN113015741A (zh) 2018-09-18 2021-06-22 桑格摩生物治疗股份有限公司 程序性细胞死亡1(pd1)特异性核酸酶
AU2019410737A1 (en) 2018-12-21 2021-06-10 CureVac SE RNA for malaria vaccines
SG11202106666UA (en) 2018-12-21 2021-07-29 Curevac Ag Methods for rna analysis
CN113474328A (zh) 2019-01-11 2021-10-01 爱康泰生治疗公司 用于脂质纳米颗粒递送活性剂的脂质
JP2022518399A (ja) 2019-01-14 2022-03-15 ジェネンテック， インコーポレイテッド Ｐｄ－１軸結合アンタゴニスト及びｒｎａワクチンを用いてがんを処置する方法
WO2020161342A1 (en) 2019-02-08 2020-08-13 Curevac Ag Coding rna administered into the suprachoroidal space in the treatment of ophtalmic diseases
US20200339638A1 (en) 2019-04-23 2020-10-29 Sangamo Therapeutics, Inc. Modulators of Chromosome 9 Open Reading Frame 72 Gene Expression and Uses Thereof
EP3986452A1 (en) 2019-06-18 2022-04-27 CureVac AG Rotavirus mrna vaccine
AU2020328855A1 (en) 2019-08-14 2022-03-03 CureVac SE RNA combinations and compositions with decreased immunostimulatory properties
AU2020407285A1 (en) 2019-12-20 2022-08-11 CureVac SE Lipid nanoparticles for delivery of nucleic acids
CA3164559A1 (en) 2020-01-31 2021-08-05 Lars Mueller Methods of inducing neoepitope-specific t cells with a pd-1 axis binding antagonist and an rna vaccine
MX2022009460A (es) 2020-02-04 2022-12-16 Curevac Ag Vacuna contra el coronavirus.
US11576966B2 (en) 2020-02-04 2023-02-14 CureVac SE Coronavirus vaccine
BR112022019781A2 (pt) * 2020-04-22 2022-12-13 BioNTech SE Vacina para o coronavírus
AU2021279312A1 (en) 2020-05-29 2022-12-15 CureVac SE Nucleic acid based combination vaccines
US20230265454A1 (en) 2020-06-04 2023-08-24 BioNTech SE RNA Replicon for Versatile and Efficient Gene Expression
KR20230051172A (ko) 2020-07-16 2023-04-17 아퀴타스 테라퓨틱스 인크. 지질 나노 입자에 사용하기 위한 양이온성 지질
US20230272052A1 (en) 2020-07-31 2023-08-31 CureVac SE Nucleic acid encoded antibody mixtures
CN113234776A (zh) * 2020-08-20 2021-08-10 深圳市瑞吉生物科技有限公司 一种Cap2结构5`帽子类似物及其制备方法和应用
US20220064596A1 (en) 2020-08-25 2022-03-03 Kite Pharma, Inc. T cells with improved functionality
WO2022043551A2 (en) 2020-08-31 2022-03-03 Curevac Ag Multivalent nucleic acid based coronavirus vaccines
IL300997A (en) 2020-09-08 2023-04-01 Genentech Inc Systems and methods for the production of pharmaceutical preparations using peristaltic pumps and restraints
MX2023006126A (es) 2020-12-09 2023-07-28 BioNTech SE Produccion de arn.
CA3171051A1 (en) 2020-12-22 2022-06-30 Curevac Ag Pharmaceutical composition comprising lipid-based carriers encapsulating rna for multidose administration
US20240156946A1 (en) 2020-12-22 2024-05-16 CureVac SE Rna vaccine against sars-cov-2 variants
WO2022137133A1 (en) 2020-12-22 2022-06-30 Curevac Ag Rna vaccine against sars-cov-2 variants
EP4087938A2 (en) 2021-01-27 2022-11-16 CureVac AG Method of reducing the immunostimulatory properties of in vitro transcribed rna
JP2024511206A (ja) 2021-03-26 2024-03-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
EP4312988A2 (en) 2021-03-31 2024-02-07 CureVac SE Syringes containing pharmaceutical compositions comprising rna
CA3171589A1 (en) 2021-05-03 2022-11-03 Moritz THRAN Improved nucleic acid sequence for cell type specific expression
AU2022271249A1 (en) 2021-05-04 2023-11-16 BioNTech SE Immunogen selection
IL309952A (en) 2021-07-29 2024-03-01 BioNTech SE Compositions and methods for treating melanoma
CA3171750A1 (en) 2021-07-30 2023-02-02 Tim SONNTAG Mrnas for treatment or prophylaxis of liver diseases
AU2022336209A1 (en) 2021-09-03 2024-01-18 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
CA3230056A1 (en) 2021-09-03 2023-03-09 Patrick Baumhof Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine
CN113957108A (zh) * 2021-09-09 2022-01-21 上海兆维科技发展有限公司 一种加帽rna的合成方法以及加帽rna转录反应液
WO2023066874A1 (en) 2021-10-18 2023-04-27 BioNTech SE Methods for determining mutations for increasing modified replicable rna function and related compositions and their use
AU2022369342A1 (en) 2021-10-18 2024-03-14 BioNTech SE Modified replicable rna and related compositions and their use
WO2023138786A1 (en) 2022-01-21 2023-07-27 BioNTech SE Analysis of rna molecules using catalytic nucleic acids
WO2023144330A1 (en) 2022-01-28 2023-08-03 CureVac SE Nucleic acid encoded transcription factor inhibitors
US12037616B2 (en) 2022-03-01 2024-07-16 Crispr Therapeutics Ag Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions
TW202403046A (zh) 2022-03-21 2024-01-16 瑞士商Ｃｒｉｓｐｒ治療公司 用於治療脂蛋白相關的疾病之方法及組成物
WO2023213378A1 (en) 2022-05-02 2023-11-09 BioNTech SE Replicon compositions and methods of using same for the treatment of diseases
WO2023227608A1 (en) 2022-05-25 2023-11-30 Glaxosmithkline Biologicals Sa Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide
WO2023237726A1 (en) 2022-06-10 2023-12-14 Pantarhei Oncology B.V. An intracellular tumor-specific variant of human zona pellucida glycoprotein 3 and nucleic acids coding therefor for use in the treatment of cancer
US11878055B1 (en) 2022-06-26 2024-01-23 BioNTech SE Coronavirus vaccine
CN114941018B (zh) * 2022-06-28 2023-09-22 翌圣生物科技(上海)股份有限公司 cap1帽类似物的合成方法
WO2024017479A1 (en) 2022-07-21 2024-01-25 BioNTech SE Multifunctional cells transiently expressing an immune receptor and one or more cytokines, their use and methods for their production
WO2024056856A1 (en) 2022-09-15 2024-03-21 BioNTech SE Systems and compositions comprising trans-amplifying rna vectors with mirna
WO2024068545A1 (en) 2022-09-26 2024-04-04 Glaxosmithkline Biologicals Sa Influenza virus vaccines
DE202023106198U1 (de) 2022-10-28 2024-03-21 CureVac SE Impfstoff auf Nukleinsäurebasis
WO2024137589A2 (en) 2022-12-20 2024-06-27 Genentech, Inc. Methods of treating pancreatic cancer with a pd-1 axis binding antagonist and an rna vaccine
GB202404607D0 (en) 2024-03-29 2024-05-15 Glaxosmithkline Biologicals Sa RNA formulation

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4854610A (en) * 1988-02-10 1989-08-08 Bertek, Inc. Method of making laminated articles and articles made therefrom
US5470967A (en) * 1990-04-10 1995-11-28 The Dupont Merck Pharmaceutical Company Oligonucleotide analogs with sulfamate linkages
US5643780A (en) * 1992-04-03 1997-07-01 Isis Pharmaceuticals, Inc. Compositions and methods for modulating RNA activity through modification of the 5' cap structure of RNA
US5653472A (en) * 1995-07-25 1997-08-05 The Standard Register Company Form having detachable wristband and labels
ATE445630T1 (de) * 1997-04-22 2009-10-15 Life Technologies Corp Verfahren zur herstellung von aslv reverser transkriptase zusammengestellt aus mehreren untereinheiten
US7017293B2 (en) * 2002-09-27 2006-03-28 Laser Band, Llc Wristband/cinch with label assembly business form and method
US7386949B2 (en) * 1997-10-14 2008-06-17 Laser Band, Llc Special precautions self-laminating wristband business form and method
US6000160A (en) * 1997-10-14 1999-12-14 Riley; James M. Computer generated moisture proof identification bracelet
US6510634B1 (en) * 1997-10-14 2003-01-28 Laser Band, Llc Multiple computer generated multi-web moisture proof identification bracelets on a single form with window
US7017294B2 (en) * 2002-09-27 2006-03-28 Laser Band, Llc Wristband/cinch with inboard label assembly business form and method
US7047682B2 (en) * 2002-09-27 2006-05-23 Laser Band, Llc Wristband/label assembly business form and method
US6016618A (en) * 1997-11-17 2000-01-25 Avery Dennison Corporation Laminated article
AU1087301A (en) * 1999-10-15 2001-04-30 Yale University Conjoined polynucleotide catalysts
US20040261644A1 (en) * 2001-09-14 2004-12-30 Stewart Thomas R. Medical patient labeling system and method
US6788687B2 (en) * 2001-10-30 2004-09-07 Qualcomm Incorporated Method and apparatus for scheduling packet data transmissions in a wireless communication system
US6836215B1 (en) * 2002-01-22 2004-12-28 The Standard Register Company Printable identification band with top strip for RFID chip attachment
US7316358B2 (en) * 2002-03-18 2008-01-08 Precision Dynamics Corporation Identification band with adhesively attached coupling elements
US7074596B2 (en) 2002-03-25 2006-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Synthesis and use of anti-reverse mRNA cap analogues
US7000951B2 (en) * 2002-09-13 2006-02-21 Chicago Tag And Label, Inc. Form having a removable wristband and labels
US6971200B2 (en) * 2002-09-13 2005-12-06 Chicago Tag & Label Form having a removable wristband and labels
US7520077B2 (en) * 2004-06-17 2009-04-21 Laser Band, Llc Cushioned wristband with self-laminating identity tag
US20050181165A1 (en) * 2002-11-13 2005-08-18 Franko Joseph D.Sr. Glue-applied resealable expanded content label
US7322613B2 (en) * 2002-12-17 2008-01-29 Precision Dynamic, Corporation Multi-part form having detachable wristband, labels and cards or the like
US7222748B2 (en) * 2003-09-26 2007-05-29 Royal Vendors, Inc. Clear door vending machine
US20050091896A1 (en) * 2003-10-30 2005-05-05 Kotik Mark M. Identification band with detachable machine-readable lables
US7320194B2 (en) * 2004-06-01 2008-01-22 Precision Dynamics Corporation Adhesive wristband without removable release liner
US7658026B2 (en) * 2006-10-27 2010-02-09 Laser Band, Llc Wristband with snap closure and patent id label
US20050285385A1 (en) * 2004-06-28 2005-12-29 Bova Antonio V Emergency medical analysis form with detachable patient identification piece and method of using same
US7417541B2 (en) * 2004-10-08 2008-08-26 Bartronics America, Inc. Identification band with regions having electro-magnetically detectable regions
US20060113788A1 (en) * 2004-11-30 2006-06-01 Laser Band, Llc. Laser printable business form having a self laminating wristband and a self laminating strip label
US7810267B2 (en) * 2005-04-21 2010-10-12 Avery Dennison Corporation Patient identification products
US20070120358A1 (en) * 2005-11-30 2007-05-31 Waggoner Bryce C Patient wristband form
US20070283607A1 (en) * 2006-06-13 2007-12-13 Printmark Industries, Inc. Printed identification band and method of manufacturing same
US20080067802A1 (en) * 2006-08-24 2008-03-20 Tri-State Hospital Supply Corporation Self-laminating label for a wristband
US8424115B2 (en) * 2006-10-27 2013-04-23 Laser Band, Llc Wristband with contoured comfort sides
EP2156428B1 (en) * 2007-06-14 2013-08-28 Precision Dynamics Corporation Printable multi-part form

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109071589A (zh) * 2016-01-29 2018-12-21 华沙大学 5′-硫代磷酸酯mRNA 5′-端(帽)类似物、包含所述类似物的mRNA、其获得方法和用途

Also Published As

Publication number Publication date
WO2008157688A3 (en) 2009-02-26
CN104072561A (zh) 2014-10-01
CN104072561B (zh) 2017-12-22
CN107501370B (zh) 2021-06-18
DK2167523T3 (da) 2014-09-08
AU2008265683A1 (en) 2008-12-24
HK1200461A1 (en) 2015-08-07
EP2167523A2 (en) 2010-03-31
CN101855231A (zh) 2010-10-06
CA2692906A1 (en) 2008-12-24
ES2500515T3 (es) 2014-09-30
EA201070030A1 (ru) 2010-06-30
AU2008265683B2 (en) 2013-08-29
EP2167523B1 (en) 2014-07-23
US8153773B2 (en) 2012-04-10
CA2692906C (en) 2016-01-19
CN107501370A (zh) 2017-12-22
EP2167523A4 (en) 2011-06-15
PT2167523E (pt) 2014-09-22
EA017740B1 (ru) 2013-02-28
CY1115525T1 (el) 2017-01-04
HRP20140771T1 (hr) 2014-11-07
US20100233757A1 (en) 2010-09-16
CN101855231B (zh) 2014-06-11
WO2008157688A2 (en) 2008-12-24
PL2167523T3 (pl) 2014-12-31

Similar Documents

Publication Publication Date Title
HK1200461A1 (en) Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap rna -
IL189602A0 (en) Indenoisoquinolinone analogs and methods of use thereof
ZA201107336B (en) Synthesis of 2'-o-fucosyllactose
HK1125961A1 (en) Preparation containing organosilicium compound and its use
EP2283132A4 (en) SELECTIVE 5-LIGATION TAGGING OF RNA
EP2647644A4 (en) RNA MODIFIED BY 2'-O
IL200013A0 (en) Indenoisoquinolinone analogs and methods of use thereof
ZA201003941B (en) Use of rr/sr-ractopamine
GB0617725D0 (en) Distribution of data to multiple recipients
HK1161122A1 (en) Use of 24-norudca 24-norudca
ZA200902300B (en) Use of modified cyclosporins
ZA201001817B (en) Crystalline hydrate of betamimetika and use as medicament thereof
GB0914782D0 (en) Perfluoroparacyclophane and methods of synthesis and use thereof
GB0722759D0 (en) Antisense oligonucleotides for the modulation of gene expression and methods relating to the use thereof
GB0710869D0 (en) Distribution of data to multiple recipients
GB0822289D0 (en) "BABOO"babyseat carry
EP2063850A4 (en) VIPR1 AS MODIFIERS OF THE E2F / RB PATHWAY AND METHODS OF USE
TWM300387U (en) Improved structure of cupulate holder
TWM292311U (en) Improved structure of cosmetics container
ZA200810632B (en) Derivativs and analogs of N-ethylquinolones and N-ethylazaquinolones
GB0707985D0 (en) Easy's
GB0804248D0 (en) Fabia's messege fragrance
TWM300202U (en) Improved structure of bottle
PL379090A1 (pl) Wykorzystanie wodoru
GB0900089D0 (en) Bathroom backcare stools- "Bacstool"